Benefit of anti-TNFalpha treatment for nephrotic syndrome in a patient with juvenile inflammatory bowel disease associated spondyloarthropathy complicated with amyloidosis and glomerulonephritis

Ann Rheum Dis. 2003 Apr;62(4):368-9. doi: 10.1136/ard.62.4.368.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Amyloidosis / therapy*
  • Antibodies, Monoclonal / therapeutic use*
  • Gastrointestinal Agents / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Inflammatory Bowel Diseases / complications*
  • Infliximab
  • Male
  • Nephrotic Syndrome / therapy*
  • Spondylarthropathies / complications*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab